Lightbridge Provides Business Update and Announces First Quarter of 2020 Earnings Results
14 May 2020 - 6:05AM
Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel
technology company, today announced financial results for the first
quarter ended March 31, 2020, as well as the Company's corporate
progress and other meaningful developments.
Seth Grae,
President & Chief Executive Officer of Lightbridge Corporation,
commented, “When COVID-19 changed our economic landscape in the
first quarter, our company adapted quickly, working hard to ensure
the safety of our employees and the continuity of our operations. I
would like to thank our team for seamlessly handling our
organizational changes while simultaneously battling the headwinds
that came with COVID-19. We closed the first quarter with
approximately $16.3M of cash on hand, continuing to maintain a
disciplined approach to managing our cash expenditures, preserving
liquidity, and optimizing our costs while we adjust our planning
for the remainder of fiscal 2020 and 2021.
“We recently
entered into our Cooperative Research and Development Agreement
(CRADA) with Battelle Energy Alliance, LLC, the operating
contractor of Idaho National Laboratory (INL), in collaboration
with the U.S. Department of Energy (DOE). The scope of this CRADA
is to design an experiment for irradiation of Lightbridge metallic
fuel material samples in the Advanced Test Reactor (ATR) at Idaho
National Lab (INL). The total project over the next 12 months has a
value of approximately $845,000, with three-quarters of this amount
funded by DOE for the scope performed by INL. We expect to begin
work under the CRADA in the coming weeks and look forward to
providing updates on our progress.
“For
Lightbridge, the initiation of our CRADA is an important
achievement on its merits. However, we also recognize the potential
opportunities for additional collaborations with DOE in the future.
The recently issued report from the Nuclear Fuel Working Group
(NFWG) outlines a dramatic shift in federal policy related to
strengthening America’s nuclear energy capabilities. These policies
include a stated goal of funding research and development for
advanced fuels and high-assay low-enriched uranium (HALEU). This
initiative, combined with our CRADA, has the potential to position
Lightbridge Fuel™ in front of key decisionmakers as these policies
are enacted. We are excited about these opportunities, as well as
others in the works, that will further our efforts towards the
development and commercialization of Lightbridge
Fuel™.
Financial Highlights
The Company maintains a strong working capital
position at March 31, 2020 and has no debt.
Cash Flows Summary
- The net change in the increase in cash and cash equivalent used
was approximately $0.5 million for the three months ended March 31,
2020 compared to the three months ended March 31, 2019. Total cash
used for the three months ended March 31, 2020 was $1.6 million
compared to $1.1 million for the three months ended March 31, 2019.
This increase consisted of the following:
- Cash used in operating activities increased approximately $0.5
million for the three months ended March 31, 2020 compared to the
three months ended March 31, 2019. This increase was primarily due
to an increase in general and administrative expenses offset by a
decrease in our research and development expenses, as a result of
the decrease in work with Framatome and Enfission as Lightbridge is
no longer conducting research and development activities with
Framatome and Enfission.
- Cash used in investing activities decreased by approximately
$1.5 million for the three months ended March 31, 2020 compared to
the three months ended March 31, 2019. This decrease was primarily
due to the inactive status of the Enfission joint venture resulting
in no capital contributions made in 2020.
- Cash provided by financing activities decreased by
approximately $1.6 million for the three months ended March 31,
2020 compared to the three months ended March 31, 2019. This
decrease was primarily due to the decrease in proceeds from
issuance of common stock in 2020, which was $0.4 million compared
to $2.0 million proceeds for the three months ended March 31,
2019.
Balance Sheet Summary
- Cash and cash equivalents were $16.3 million at March 31, 2020,
compared to $17.9 million at December 31, 2019, a decrease of
$1.6 million in cash and cash equivalents for the three months
ended March 31, 2020.
- Total assets were $18.5 million at March 31, 2020 and total
liabilities were $0.5 million at March 31, 2020. Working capital
was $16.2 million at March 31, 2020 versus $18.1 million at
December 31, 2019. This decrease of $1.9 million in working capital
was due primarily to the factors stated above in the cash flow
summary.
- Stockholders’ equity was $18.0 million at March 31, 2019 versus
$19.9 million at December 31, 2019. This decrease was primarily due
to the net loss reported for the three months ended March 31,
2020.
Operations Summary
- General and administrative expenses for the three months ended
March 31, 2020 were $1.9 million compared to $1.3 million for the
three months ended March 31, 2019. This increase of approximately
$0.6 million was due to an increase in professional fees of
approximately $0.4 million, an increase in employee compensation
and employee benefits of approximately $0.1 million and an increase
in severance payments of $0.2 million, due to employee layoffs at
March 31, 2020. These increases were offset by a decrease in
stock-based compensation of approximately $0.1 million, due to the
decrease in stock option expense for prior stock option awards that
have become fully vested in prior reporting periods.
- Lightbridge’s total corporate research and development costs
amounted to $0.4 million for the three months ended March 31, 2020
compared to $0.9 million for the three months ended
March 31, 2018. This decrease of $0.5 million was
primarily due to the decrease in R&D work with Framatome and
Enfission as Lightbridge is no longer conducting R&D activities
with Framatome and Enfission.
- Total net other operating expenses were $0 for the three months
ended March 31, 2020 compared to $0.9 million for the three months
ended March 31, 2019 a decrease of $0.9 million. This decrease is a
result of the inactive status of the Enfission joint venture at
March 31, 2020 and December 31, 2019.
- Total net other income was $0.1 million for three months ended
March 31, 2020 and 2019, which represents interest income on our
cash balances.
- Net loss for the three months ended March 31, 2020 was $2.3
million compared to $3.1 million for 2019. This decrease of $0.8
million was primarily due to the factors stated above in the
operations summary.
FISCAL YEAR 2019 CONFERENCE CALL &
WEBCAST
Lightbridge
will host a conference call on Thursday, May 14th at 4:00 p.m.
Eastern Time to discuss the Company's financial results for the
three months ended March 31, 2020, as well as the Company's
corporate progress and other meaningful developments.
Interested
parties can access the conference call by calling 877-407-3088 for
U.S. callers, or 201-389-0927 for international callers. The call
will be available on the Company’s website via webcast at
https://www.ltbridge.com/investors/news-events/ir-calendar.
The conference call will be led
by Seth Grae, President and Chief Executive Officer and other
Lightbridge executives will also be available to answer
questions.
About Lightbridge
Corporation
Lightbridge (NASDAQ: LTBR) is an advanced
nuclear fuel technology development company based in Reston,
Virginia, United States. The Company is developing Lightbridge
Fuel™, a proprietary next-generation nuclear fuel technology for
current and future reactors, which significantly enhances the
economics, safety, and proliferation resistance of nuclear power.
Lightbridge invented, patented, and has independently validated its
technology, with goals of preventing climate change and enhancing
national security. The Company has assembled a world-class
development team. Four large electric utilities that generate about
half of America’s nuclear power advise Lightbridge on fuel
development and deployment. The Company plans to operate under a
licensing and royalty model, and based on the increased power
generated by Lightbridge-designed fuel expects to offer high ROI
for operators of existing and new reactors. For more
information please visit: www.ltbridge.com.
To receive Lightbridge Corporation updates via e-mail, subscribe
at https://www.ltbridge.com/investors/news-events/email-alerts
Lightbridge is on Twitter. Sign up to follow
@LightbridgeCorp at http://twitter.com/lightbridgecorp.
Forward Looking Statements
With the exception of historical matters, the
matters discussed in this news release are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements regarding the timing and
outcome of research and development activities, other steps to
commercialize Lightbridge Fuel™ and future governmental support and
funding for nuclear energy. These statements are based on current
expectations on the date of this news release and involve a number
of risks and uncertainties that may cause actual results to differ
significantly from such estimates. The risks include, but are not
limited to: the Company’s ability to commercialize its nuclear fuel
technology; the degree of market adoption of the Company's product
and service offerings; market competition; dependence on strategic
partners; demand for fuel for nuclear reactors; the Company's
ability to manage its business effectively in a rapidly evolving
market; changes in the political environment; risks associated with
the further spread of COVID-19, including the ultimate impact of
COVID-19 on people, economies, and the Company’s ability to access
capital markets; the outcome of the arbitration with the Company’s
former joint venture partner and dissolution of the Enfission joint
venture; as well as other factors described in Lightbridge's
filings with the U.S. Securities and Exchange Commission.
Lightbridge does not assume any obligation to update or revise any
such forward-looking statements, whether as the result of new
developments or otherwise, except as required by law. Readers are
cautioned not to put undue reliance on forward-looking
statements.
A further description of risks and uncertainties
can be found in Lightbridge’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2019 and in its subsequent reports
on Form 10-Q, including in the sections thereof captioned “Risk
Factors” and “Forward-Looking Information and Factors That May
Affect Future Results”, as well as in its subsequent reports on
Form 8-K, all of which are filed with the U.S. Securities and
Exchange Commission and available at http://www.sec.gov/ and
www.ltbridge.com.
Investor Relations Contact:Porter, LeVay &
Rose, Inc.Matthew AbenanteTel: 212-564-4700 ir@ltbridge.com
*** tables follow ***
LIGHTBRIDGE CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
March 31, |
|
|
December 31, |
|
|
|
2020 |
|
|
2019 |
|
|
|
Unaudited |
|
|
|
|
ASSETS |
|
Current Assets |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
16,334,353 |
|
|
$ |
17,958,989 |
|
Other receivable from joint venture |
|
|
— |
|
|
|
400,000 |
|
Prepaid expenses and other current assets |
|
|
344,652 |
|
|
|
47,371 |
|
Total Current Assets |
|
|
16,679,005 |
|
|
|
18,406,360 |
|
Other Assets |
|
|
|
|
|
|
|
|
Patent costs |
|
|
1,802,907 |
|
|
|
1,798,484 |
|
Total Assets |
|
$ |
18,481,912 |
|
|
$ |
20,204,844 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
Current Liabilities |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
$ |
485,693 |
|
|
$ |
350,299 |
|
Total Current Liabilities |
|
|
485,693 |
|
|
|
350,299 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies – (Note 5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity |
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value, 10,000,000 authorized
shares: |
|
|
|
|
|
|
|
|
Convertible Series A preferred shares, 745,896 shares and 757,770
shares issued and outstanding at March 31, 2020 and December 31,
2019, respectively (liquidation preference $2,641,401 and
$2,636,764 at March 31, 2020 and December 31, 2019,
respectively) |
|
|
745 |
|
|
|
757 |
|
Convertible Series B preferred shares, 2,666,667 issued and
outstanding at March 31, 2020 and December 31, 2019, (liquidation
preference $4,649,140 and $4,569,180 at March 31, 2020 and December
31, 2019, respectively) |
|
|
2,667 |
|
|
|
2,667 |
|
Common stock, $0.001 par value, 8,333,333 authorized, 3,363,679
shares and 3,252,371 shares issued and outstanding as of March 31,
2020 and December 31, 2019, respectively |
|
|
3,364 |
|
|
|
3,252 |
|
Additional paid-in capital |
|
|
134,338,275 |
|
|
|
133,932,615 |
|
Accumulated deficit |
|
|
(116,348,832 |
) |
|
|
(114,084,746 |
) |
Total Stockholders’ Equity |
|
|
17,996,219 |
|
|
|
19,854,545 |
|
Total Liabilities and Stockholders’ Equity |
|
$ |
18,481,912 |
|
|
$ |
20,204,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIGHTBRIDGE
CORPORATIONCONSOLIDATED STATEMENTS OF
OPERATIONS
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2020 |
|
|
2019 |
|
Revenue |
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Operating Expenses |
|
|
|
|
|
|
|
|
General and administrative |
|
|
1,936,755 |
|
|
|
1,357,762 |
|
Research and development |
|
|
389,824 |
|
|
|
922,235 |
|
Total Operating Expenses |
|
|
2,326,579 |
|
|
|
2,279,997 |
|
|
|
|
|
|
|
|
|
|
Other Operating Income and (Loss) |
|
|
|
|
|
|
|
|
Other income from joint venture |
|
|
— |
|
|
|
355,281 |
|
Equity in loss from joint venture |
|
|
— |
|
|
|
(1,295,032 |
) |
Total Other Operating Income and (Loss) |
|
|
— |
|
|
|
(939,751 |
) |
|
|
|
|
|
|
|
|
|
Operating Loss |
|
|
(2,326,579 |
) |
|
|
(3,219,748 |
) |
|
|
|
|
|
|
|
|
|
Other Income and (Expenses) |
|
|
|
|
|
|
|
|
Interest income |
|
|
62,493 |
|
|
|
109,221 |
|
Total Other Income and (Expenses) |
|
|
62,493 |
|
|
|
109,221 |
|
|
|
|
|
|
|
|
|
|
Net Loss before Income Taxes |
|
|
(2,264,086 |
) |
|
|
(3,110,527 |
) |
|
|
|
|
|
|
|
|
|
Income Taxes |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Net Loss |
|
$ |
(2,264,086 |
) |
|
$ |
(3,110,527 |
) |
|
|
|
|
|
|
|
|
|
Accumulated Preferred Stock Dividend |
|
|
(125,911 |
) |
|
|
(120,815 |
) |
Deemed additional dividend on preferred stock dividend due to
beneficial conversion feature |
|
|
(54,317 |
) |
|
|
(51,371 |
) |
|
|
|
|
|
|
|
|
|
Net Loss Attributable to Common Stockholders |
|
$ |
(2,444,314 |
) |
|
$ |
(3,282,713 |
) |
|
|
|
|
|
|
|
|
|
Net Loss Per Common Share, |
|
|
|
|
|
|
|
|
Basic and Diluted |
|
$ |
(0.74 |
) |
|
$ |
(1.14 |
) |
|
|
|
|
|
|
|
|
|
Weighted Average Number of Common Shares Outstanding |
|
|
3,294,998 |
|
|
|
2,885,921 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIGHTBRIDGE
CORPORATIONCONSOLIDATED STATEMENTS OF CASH
FLOWS
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2020 |
|
|
2019 |
|
Operating Activities: |
|
|
|
|
|
|
Net Loss |
|
$ |
(2,264,086 |
) |
|
$ |
(3,110,527 |
) |
Adjustments to reconcile net loss from operations to net cash used
in operating activities: |
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
6,085 |
|
|
|
335,013 |
|
Equity in loss from joint venture |
|
|
— |
|
|
|
1,295,032 |
|
Changes in operating working capital items: |
|
|
|
|
|
|
|
|
Other receivable from joint venture |
|
|
400,000 |
|
|
|
(265,548 |
) |
Prepaid expenses and other assets |
|
|
(297,281 |
) |
|
|
(157,314 |
) |
Accounts payable and accrued liabilities |
|
|
135,394 |
|
|
|
356,566 |
|
Net Cash Used In Operating Activities |
|
|
(2,019,888 |
) |
|
|
(1,546,778 |
) |
|
|
|
|
|
|
|
|
|
Investing Activities: |
|
|
|
|
|
|
|
|
Investment in joint venture |
|
|
— |
|
|
|
(1,440,000 |
) |
Patent costs |
|
|
(4,423 |
) |
|
|
(108,761 |
) |
Net Cash Used In Investing Activities |
|
|
(4,423 |
) |
|
|
(1,548,761 |
) |
|
|
|
|
|
|
|
|
|
Financing Activities: |
|
|
|
|
|
|
|
|
Net proceeds from the issuance of common stock |
|
|
399,675 |
|
|
|
1,986,485 |
|
Net Cash Provided by Financing Activities |
|
|
399,675 |
|
|
|
1,986,485 |
|
|
|
|
|
|
|
|
|
|
Net Decrease In Cash and Cash Equivalents |
|
|
(1,624,636 |
) |
|
|
(1,109,054 |
) |
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents, Beginning of Period |
|
|
17,958,989 |
|
|
|
24,637,295 |
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents, End of Period |
|
$ |
16,334,353 |
|
|
$ |
23,528,241 |
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosure of Cash Flow Information: |
|
|
|
|
|
|
|
|
Cash paid during the period: |
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
— |
|
|
$ |
— |
|
Income taxes paid |
|
$ |
— |
|
|
$ |
— |
|
Non-Cash Financing Activities: |
|
|
|
|
|
|
|
|
Accumulated preferred stock dividend |
|
$ |
180,228 |
|
|
$ |
172,186 |
|
Conversion of Series A convertible preferred stock to common stock
and payment of paid-in- kind dividends to Series A preferred
stockholder |
|
$ |
8,975 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Lightbridge (NASDAQ:LTBR)
Historical Stock Chart
From Apr 2024 to May 2024
Lightbridge (NASDAQ:LTBR)
Historical Stock Chart
From May 2023 to May 2024